NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

40 hedge funds and large institutions have $10.7M invested in NeuBase Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.91%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
12
Reduced
6
Closed
6
Calls
$140K
Puts
$146K
Net Calls
-$6K
Net Calls Change
-$4K